3-hydroxybutyric acid has been researched along with Abdominal Obesity in 1 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In women with ovarian or endometrial cancer, a KD results in selective loss of fat mass and retention of lean mass." | 2.87 | A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer. ( Alvarez, RD; Arend, RC; Bevis, KS; Cohen, CW; Fontaine, KR; Gower, BA; Huh, WK; Kim, KH; Leath, CA; Straughn, JM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, CW | 1 |
| Fontaine, KR | 1 |
| Arend, RC | 1 |
| Alvarez, RD | 1 |
| Leath, CA | 1 |
| Huh, WK | 1 |
| Bevis, KS | 1 |
| Kim, KH | 1 |
| Straughn, JM | 1 |
| Gower, BA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Targeted Disruption to Cancer Metabolism Through Dietary Macronutrient Modification[NCT03171506] | 57 participants (Actual) | Interventional | 2015-11-09 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 3-hydroxybutyric acid and Abdominal Obesity
| Article | Year |
|---|---|
A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.
Topics: 3-Hydroxybutyric Acid; Body Composition; Body Fluid Compartments; Diet, Ketogenic; Endometrial Neopl | 2018 |